Magnetic Insight Raises $17M Series B to Expand Magnetic Particle Imaging and Monitoring Technology into Clinical Applications

News
2022
2021
Archive

June 5, 2010

SEMPRUS BIOSCIENCES SELECTED AS ONE OF THE “50 COMPANIES TO WATCH” IN MD+DI JUNE ISSUE
June 1, 2010

IKARIA® NAMES NEW HEAD OF RESEARCH & DEVELOPMENT
May 5, 2010

PEARL THERAPEUTICS’ BRONCHODILATOR COMBINATION THERAPEUTIC FOR COPD TO BE PRESENTED AT THE AMERICAN THORACIC SOCIETY ANNUAL MEETING
April 14, 2010

SYNOSIA THERAPEUTICS’ SYN-115 IMPROVES MOTOR AND NON-MOTOR FUNCTION IN PATIENTS WITH MILD-TO-MODERATE PARKINSON’S DISEASE
April 7, 2010

ACHAOGEN COMPLETES $56 MILLION SERIES C FINANCING
March 30, 2010

IKARIA® ACQUIRES NEW DRUG APPLICATION FOR LUCASSIN®
March 29, 2010

PEARL THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM PHASE 1 TRIAL OF PT003, A BRONCHODILATOR COMBINATION THERAPEUTIC FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND INITIATION OF PHASE 2B TRIAL
February 17, 2010

MARCADIA INITIATES PHASE I CLINICAL TRIAL OF GLP-1/GIP DUAL AGONIST MAR701
February 1, 2010

SYNOSIA ANNOUNCES POSITIVE INTERIM RESULTS FOR POTENTIAL FIRST-IN-CLASS TREATMENT FOR PARKINSON’S DISEASE
February 1, 2010

PEARL THERAPEUTICS RAISES $15 MILLION TO ADVANCE PT003, LAMA/LABA COMBINATION BRONCHODILATOR FOR COPD, INTO PHASE 2B STUDY

© 2022 5AM Venture Management LLC